Health
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia | NEJM – nejm.org
Original Article from The New England Journal of Medicine — Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Trial Design and Randomization
In this trial, which was conducted at 62 hospitals in nine countries in Europe and North America (Canada, Denmark, France, Germany, Italy, the Netherlands, Spain, the United Kingdom, and the United States), we enrolled adults (18 years of age) with severe Covid-19 pneumonia, as confirmed by positive polymerase-chain-reaction (PCR) assay of any body fluid and evidenced by bilateral chest infiltrates on chest radiography or computed tomography. Eligible patients had…
-
General18 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General21 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
General23 hours agoFirst Nations children’s commissioner must have power to make change: advocates
-
Business23 hours agoHere are the 3 Australian stocks I’d tell a new investor to buy ASAP